JR10 E-cigarette | Lighting Up the Future of Smoking Alternatives

Jan.14.2025
 JR10 E-cigarette | Lighting Up the Future of Smoking Alternatives

Making smoking healthier and more personalized, the JR10 e-cigarette is specially designed for the UK market and future European markets. With its excellent design and attractive appearance, it stands out as a leader among smoking alternatives.

 

 JR10 E-cigarette | Lighting Up the Future of Smoking Alternatives
The stylish and simple JR10 e-cigarette features a semi-transparent cartridge design and colorful lights that instantly catch the eye.

 

 

Core Highlights: Long-lasting Battery Life and Powerful Performance

 

 

The JR10 is equipped with a 650mAh rechargeable battery, supporting USB-C fast charging. It can be fully charged in less than an hour, allowing you to maintain smooth use whether at home, in the office, or on the go. Coupled with a large 2+10ML semi-transparent cartridge, it supports approximately 10,000 draws, truly achieving a perfect balance of efficiency and long-lasting battery life.

 

Imagine: No need for frequent charging and oil refills, easily meeting the needs of the whole day, making your life more convenient and efficient.

 

 JR10 E-cigarette | Lighting Up the Future of Smoking Alternatives
The semi-transparent cartridge design, makes the oil level clear at a glance, saying goodbye to dry burns and worries; the screen displays the battery level in real-time, making use smarter.

 

 

Colorful Lights Add Fun to the Experience

 

 

Every draw lights up the semi-transparent cartridge with a rainbow of colors, providing a cool visual experience. This is not just a function but also a fashion statement, suitable for modern users who pursue personalization.

 

 

Automatic Airflow Activation Mechanism, Mouth-to-Lung (MTL) Style for a More Natural Fit

 

 

The JR10 adopts an automatic airflow activation mechanism, no button operation is needed, just pick up and use, especially suitable for users who prefer the MTL (mouth-to-lung) drawing style, with a smooth and natural draw.

 

 JR10 E-cigarette | Lighting Up the Future of Smoking Alternatives
Users enjoy the JR10 effortlessly, with the MTL design closer to the traditional smoking sensation, satisfying the need for a real smoking experience.

 

 

Details are King: Thoughtful Design for Every Moment

 

  • Battery Level Screen Display: Always in control of the device status, no need to worry about the battery running out suddenly.
  • 20mg Nicotine Concentration: Precise control of nicotine cravings, meeting needs while complying with the strict regulations of the European market.
  • Semi-transparent cartridge Design: Clear oil level visibility, more worry-free use.

 

 

Born for the Future: A Dual Commitment to Safety and Environmental Sustainability

 

 

As an innovative product focused on the UK and European markets, the JR10 not only complies with local laws and health standards but also offers sustainable choices through more environmentally friendly designs.

 

The above 2+10 product is developed by Lanavape, which has not yet been officially launched on the website.

 

LANAVAPE is a well-known e-cigarette brand factory headquartered in Shenzhen, China, ranking in the top five in the Southeast Asian market and trusted by consumers. The company focuses on the research and production of disposable, Replaceable pod, and open pod-style e-cigarettes. Now, LANAVAPE is actively expanding into the European market, offering healthier and more efficient smoking alternatives to users worldwide.

JUUL Purchasers Ask Ninth Circuit to Preserve Antitrust Classes in Case Over Altria’s $12.8 Billion Investment
JUUL Purchasers Ask Ninth Circuit to Preserve Antitrust Classes in Case Over Altria’s $12.8 Billion Investment
Private antitrust litigation stemming from Altria's 2018 $12.8 billion investment for a 35% economic interest in JUUL is advancing before the U.S. Court of Appeals for the Ninth Circuit. Direct purchasers, indirect purchasers and indirect resellers of JUUL products filed answering briefs this week seeking to preserve class certifications granted by a California federal court in February. Altria and JUUL argue that individual consumers and large distributors differ too much in purchasing terms to remain in a single direct-purchaser class, while a separate dispute concerns whether California antitrust law can apply to indirect purchasers across 27 jurisdictions. A September trial has been put on hold during the appeal.
Sep.23
China Tobacco Plans CNY 60 Billion Investment in ICBC, Agricultural Bank as Strategic Ties Extend Beyond Equity
China Tobacco Plans CNY 60 Billion Investment in ICBC, Agricultural Bank as Strategic Ties Extend Beyond Equity
China National Tobacco Corporation and several subsidiaries plan to invest a combined CNY 60 billion ($8.7 billion) in share placements by Industrial and Commercial Bank of China and Agricultural Bank of China as strategic investors. The agreements extend beyond equity investment to corporate governance, banking services and supply-chain finance. The filings also disclose 2025 data on China Tobacco’s tax and profit contributions and industry scale.
Sep.07
Virginia Tobacco Retail Permit Takes Effect October 1, Covering Vapes as More Than 3,000 Businesses Apply in September
Virginia Tobacco Retail Permit Takes Effect October 1, Covering Vapes as More Than 3,000 Businesses Apply in September
Virginia's new retail tobacco permit system took effect October 1, requiring sellers of vapes, nicotine products and related devices and accessories to obtain a Retail Tobacco Permit for each business location. Virginia ABC said more than 3,000 businesses applied in September alone, creating a processing backlog. Qualifying applicants that filed before October 1 may temporarily operate under a Letter of Authorization. The new store-level permit also sits alongside Virginia's existing vape product directory, where sales of unlisted liquid nicotine or nicotine vapor products can trigger civil penalties starting at $5,000.
Regulations
Oct.03
China Tobacco Supply-Chain Leader Huabao’s Three-Way Transformation Takes Hold as Overseas Revenue Jumps 216%, Non-Flavor Businesses Reach 42.2% and the Company Expands Into Global Next-Generation Tobacco Supply Chains
China Tobacco Supply-Chain Leader Huabao’s Three-Way Transformation Takes Hold as Overseas Revenue Jumps 216%, Non-Flavor Businesses Reach 42.2% and the Company Expands Into Global Next-Generation Tobacco Supply Chains
Huabao’s H1 2026 results show the company advancing across three connected fronts: international expansion, entry into next-generation tobacco supply chains and diversification beyond its traditional tobacco-related base. Overseas revenue rose 216.08% to CNY 96.02 million, while non-flavor businesses reached 42.2% of total revenue. Huabao also said it had entered the supply chains of leading global tobacco customers, as its nutrition, food ingredient, fragrance and personal-care businesses gained ground in Europe, Southeast Asia, Australia and New Zealand. However, adjusted net profit increased only 2.78%, and next-generation tobacco revenue was not separately disclosed, showing that the transformation is reshaping revenue and customer exposure but has yet to translate fully into underlying earnings.
Aug.28
Former Roche Neuroscience and Rare Diseases Communications Director Ria Kioupritzi Joins PMI as Scientific Affairs Director
Former Roche Neuroscience and Rare Diseases Communications Director Ria Kioupritzi Joins PMI as Scientific Affairs Director
Eleftheria (Ria) Kioupritzi, a biopharmaceutical professional with more than 15 years of experience, has joined Philip Morris International as Director Scientific Affairs within Corporate Affairs. She previously served at Roche as Senior Scientific Communications Director for Neuroscience and Rare Diseases and worked extensively in spinal muscular atrophy. Her earlier career also covered competitive intelligence, clinical and regulatory monitoring, pipeline development and launch preparation. During her time working in Roche's SMA field, Evrysdi passed through several U.S. FDA milestones, including its initial approval, an expanded indication for younger infants and approval of a tablet formulation. Public records do not show that Kioupritzi herself led the FDA submissions.
Sep.22
JTI Invests ₱2.1 Billion to Upgrade Batangas Manufacturing Hub, Adds First Southeast Asia DIET Facility
JTI Invests ₱2.1 Billion to Upgrade Batangas Manufacturing Hub, Adds First Southeast Asia DIET Facility
JTI Asia Manufacturing Corp. has invested ₱2.1 billion, or about $37 million, in its manufacturing site in Malvar, Batangas, Philippines, to expand tobacco-processing capabilities. About ₱1.9 billion is allocated to JTI's first Dry Ice Expanded Tobacco, or DIET, facility in Southeast Asia, while more than ₱177 million has been spent on expanding its Controlled Atmosphere treatment facility. The Batangas plant supplies the Philippine market and exports to 22 overseas markets, making it one of JTI's key manufacturing hubs in Asia.
Sep.24